Subcutaneous progesterone administration provides a similar ongoing pregnancy rate compared with intramuscular progesterone administration in hormone replacement therapy frozen embryo transfer cycles

• Egile Nagusiak: Fazilet K. Boynukalin, M.D., MSc (Egilea), Remzi Abali, M.D (Egilea), Meral Gultomruk, B.Sc (Egilea), Berfu Demir, M.D., M.Sc (Egilea), Zalihe Yarkiner, M.Sc., Ph.D (Egilea), Guvenc Karlikaya, M.D (Egilea), Mustafa Bahceci, M.D (Egilea), Dominique de Ziegler, M.D (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2023-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective: To compare the ongoing pregnancy rates (OPRs) for subcutaneous progesterone (SC-P) to intramuscular progesterone (IM-P) in hormone replacement therapy used in frozen embryo transfer (FET) cycles. Design: Prospective nonrandomized cohort study. Setting: Private fertility clinic. Patient(s)...